All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know AML.
Introducing
Now you can personalise
your AML Hub experience!
Bookmark content to read later
Select your specific areas of interest
View content recommended for you
Find out moreThe AML Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the AML Hub cannot guarantee the accuracy of translated content. The AML Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
Bookmark this article
Coculova M, et al., analyzed whether there was a correlation between the expression of P-glycoprotein and the expression of nestin in Acute Myeloid Leukemia (AML) cell lines (SKM-1 and MOLM-13). The study is of interest as the findings could further elucidate the mechanisms by which Multidrug Resistance (MDR) occurs during chemotherapy treatment. The data were published in Leukemia Research in July 2016.
In conclusion, a causal relationship was observed between expression of P-glycoprotein and the expression of nestin in AML cell lines. This data suggests that the targeting of the P-glycoprotein could provide a mode of preventing multiple drug resistance to chemotherapy agents used to treat leukemia.
The expression of P-glycoprotein in leukemia cells is associated with the upregulated expression of nestin, a class 6 filament protein.
Subscribe to get the best content related to AML delivered to your inbox